These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Experimental study of combined treatment with tacrolimus and donor splenocytes via the portal vein in small bowel transplantation. Miyauchi T, Ishikawa M, Tashiro S, Hisaeda H, Himeno K. J Med Invest; 2001 Aug; 48(3-4):157-65. PubMed ID: 11694955 [Abstract] [Full Text] [Related]
3. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum. Yoshimura N, Matsui S, Hamashima T, Lee CJ, Ohsaka Y, Oka T. Transplantation; 1990 Jan; 49(1):167-71. PubMed ID: 2301007 [Abstract] [Full Text] [Related]
4. Evidence that indefinite survival of small bowel allografts achieved by a brief course of cyclosporine or FK506 is not due to systemic hyporesponsiveness. Langrehr JM, Hoffman RA, Demetris AJ, Lee KK, Neuhaus P, Wren SM, Ildstad ST, Schraut WH. Transplantation; 1992 Sep; 54(3):505-10. PubMed ID: 1384185 [Abstract] [Full Text] [Related]
5. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts. Boyle MJ, Dumble LJ. Cell Transplant; 1999 Sep; 8(5):543-8. PubMed ID: 10580348 [Abstract] [Full Text] [Related]
7. [Cyclosporin and portal venous inoculation of donor splenocytes prolongs cardiac allograft survival in mice]. Zhou HK, Yu LX, Zheng SB, Min ZL, Zhu YH. Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1093-5. PubMed ID: 12480604 [Abstract] [Full Text] [Related]
9. [Effects of portal venous administration with allogenic cells on renal allograft survival in the rat]. Hamashima T, Yoshimura N, Matsui S, Lee CJ, Oka T. Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1752-7. PubMed ID: 2480516 [Abstract] [Full Text] [Related]
10. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats. Ochiai T, Nakajima K, Nagata M, Hori S, Asano T, Isono K. Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689 [Abstract] [Full Text] [Related]
12. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival. Boyle MJ, Baghdassarian V, Stepkowski SM, Dumble LJ, Kahan BD. Cell Transplant; 1998 Dec; 7(3):247-56. PubMed ID: 9647434 [Abstract] [Full Text] [Related]
17. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Stepkowski SM, Chen HF, Wang ME, Daloze P, Kahan BD. Transplantation; 1992 Feb 15; 53(2):258-64. PubMed ID: 1738917 [Abstract] [Full Text] [Related]
19. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat. Nishi M, Herbort CP, Matsubara M, Morishita Y, Nishimura M, Nieda M, Mori S, Mochizuki M. Invest Ophthalmol Vis Sci; 1993 Jul 15; 34(8):2477-86. PubMed ID: 7686893 [Abstract] [Full Text] [Related]
20. Graft persistence effectively induces and maintains donor-specific unresponsiveness. Nishinaka H, Nakafusa Y, Hirano T, Takeda K, Kawano R, Nakano M, Arima T, Nakamura K, Kamei T, Tanaka M. J Surg Res; 1997 Mar 15; 68(2):145-52. PubMed ID: 9184673 [Abstract] [Full Text] [Related] Page: [Next] [New Search]